MHRA Approves Lurbinectedin for Adults with Extensive-Stage Small Cell Lung Cancer
As with All Licensed Medicines, the MHRA Will Keep the Safety and Effectiveness of Lurbinectedin Under Close Review
What do you think?
Log in to reply to this SHMOOZ post.
There are no replies yet.